drug
bromfenac sodium
Marketedupdated 3mo agoby Sentiss Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying bromfenac sodium
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 5, 2029
~2.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Nov 11, 2033method-of-use (U-1933)US 9517220
- Nov 19, 2032formulationUS 10085958
- Mar 5, 2029formulationUS RE502182.5y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 30m ago
Found something off?
comments(0)
5-min edit window · permanent after that